Ultrafiltration for decompensated heart failure: Renal implications

Heart

Volumn 95, Issue 13, 2009, Pages 1047-1051

  Kazory, A ^a   Ross, E A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FUROSEMIDE;

CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; DECOMPENSATED HEART FAILURE; DIURESIS; DRUG MECHANISM; EXTRACORPOREAL ULTRAFILTRATION; FEEDBACK SYSTEM; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEMODIAFILTRATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TUBULOGLOMERULAR FEEDBACK; PARACENTESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; ULTRAFILTRATION;

DIURETICS; HEART FAILURE; HUMANS; RENAL INSUFFICIENCY; ULTRAFILTRATION;

EID: 67649583708     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.160218     Document Type: Review

References (46)

1. Bibbins-Domingo K, Lin F, Vittinghoff E, et al. Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 2004;44:1592-1600 (Pubitemid 39369791)
2. Ezekowitz J, McAlister FA, Humphries KH, et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004;44:1587-1592 (Pubitemid 39369790)
3. Shlipak MG, Smith GL, Rathore SS, et al. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol 2004;15:2195-2203 (Pubitemid 39031358)
4. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113:671-678 (Pubitemid 43754331)
5. Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006;47:1987-1996
6. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-210 (Pubitemid 30451778)
7. Drazner MH, Rame JE, Stevenson LW, et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. New Engl J Med 2001;345:574-581 (Pubitemid 32772099)
8. Smilde TD, Hillege HL, Navis G, et al. Impaired renal function in patients with iaschemic and non-ischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J 2004;148:165-172 (Pubitemid 38900497)
9. Damman K, Navis G, Smilde TD, et al. Decreased cardiac output, venous congeation and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007;9:872-878 (Pubitemid 47332311)
10. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004;43:61-67 (Pubitemid 38045917)
11. Krumholz HM, Chen YT, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol 2000;85:1110-1113 (Pubitemid 30214258)
12. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999;138:285-290 (Pubitemid 29379679)
13. Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 2008;36(Suppl):75-88S.
14. Gottlieb SS, Abraham W, Butler J, et al. The prognostic impact of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002;8:136-141 (Pubitemid 34857278)
15. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA 2002;287:628-640 (Pubitemid 34252016)
16. Kazory A, Ross EA. Contemporary trends in the pharmacologic and extracorporeal management of heart failure: a nephrologic perspective. Circulation 2008;117:975-983 (Pubitemid 351272594)
17. Lang CC, Mancini DM. Non-cardiac comorbidities in chronic heart failure. Heart 2007;93:665-671 (Pubitemid 46808262)
18. Ellison DH. Diuretic therapy and resistance in congestive heart failure. Cardiology 2001;96:132-143 (Pubitemid 34114123)
19. Obermuller N, Bernstein P, Velasquez H, et al. Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney. Am J Physiol 1995;269:F900-10. (Pubitemid 3020692)
20. Packer M, Kessler PD, Gottlieb SS. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management. Postgrad Med J 1986;62(1 Suppl):179-182 (Pubitemid 16057551)
21. Beuttler JJ, Boer WH, Koomans HA, et al. Renal hemodynamics and tubular response to furosemide in man during normal and restricted sodium intake. Nephron 1990;54:208-213 (Pubitemid 20039683)
22. Smith FG, Abraham J. renal and rennin responses to furosemide in conscious lambs during postnatal maturation. Can J Physiol Pharmacol 1995;73:107-112
23. Gottlieb SS, Skettino SL, Wolff A, et al. Effects of BG 9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 2000;35:56-59 (Pubitemid 30061259)
24. Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002;105:1348-1353 (Pubitemid 34260427)
25. Mackay IG, Muir AL, Watson Ml. Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man. Br J Clin Pharmacol 1984;17:513-519 (Pubitemid 14057456)
26. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-216 (Pubitemid 40348525)
27. Ross EA, Kazory A. Hemodialysis and continuous therapies. In: Wilcox CS, Tisher CC, eds. Handbook of nephrology and hypertension. 6th edn. Philadelphia: Lippincott Williams & Wilkins (Publ), 2008:307-320
28. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. New Engl J Med 1999;341:577-585 (Pubitemid 29384167)
29. Ali SS, Olinger CC, Sobotka PA, et al. Enhanced sodium extraction with ultrafiltration compared to intravenous diuretics. J Card Fail 2006;12(1 Suppl):114S.
30. Firth JD, Raine AE, Ledingham JG. Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1988;1:1033-1035
31. Mullens W, Abrahams Z, Francis GS, et al. Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure. J Cardiac Fail 2008;14:508-514 (Pubitemid 352040863)
32. Agostoni P, Marenzi G. Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 2001;96:183-189 (Pubitemid 34114128)
33. Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-683 (Pubitemid 46205043)
34. Libetta C, Sepe V, Zucchi M, et al. Standard hemodiafiltration improves diuretic responsiveness in advanced congestive heart failure. Cardiology 2006;105:122-123 (Pubitemid 43189787)
35. Libetta C, Sepe V, Zucchi M, et al. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol Dial Transplant 2007;22:2013-2019 (Pubitemid 47244775)
36. Schroeder KL, Sallustio JE, Ross EA. Continuous hematocrit monitoring during intradialytic hypotension: precipitous decline in plasma refill rates. Nephrol Dial Transplant 2004;19:652-656 (Pubitemid 38263126)
37. Kalantar-Zadeh K, Block G, Horwich T, et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004;43:1439-1444 (Pubitemid 38496352)
38. Reddan DN, Szczech LA, Hasselblad V, et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol 2005;16:2162-2169 (Pubitemid 41716449)
39. Kosch M, Levers A, Fobker M, et al. Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress. Nephrol Dial Transplant 2003;18:1370-1375 (Pubitemid 36826959)
40. Costanzo MR, Saltzberg M, O'Sullivan J, et al. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005;46:2047-2051 (Pubitemid 41713590)
41. Dahle TG, Blake D, Ali SS, et al. Large volume ultrafiltration for acute decompensated heart failure using standard peripheral intravenous catheters. J Card Fail 2006;12:349-352 (Pubitemid 43817585)
42. Liang KV, Hiniker AR, Williams AW, et al. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail 2006;12:707-714 (Pubitemid 44889284)
43. Smilde TD, van Veldhuisen DJ, Navis G, et al. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 2006;114:1572-1580 (Pubitemid 44547427)
44. Rogers HL, Marshall J, Bock J, et al. A randomized, controlled trial of the renal effect of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail 2008;14:1-5.
45. Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure. J Am Coll Cardiol 2005;46:2043-2046
46. Jaski BE, Romeo A, Ortiz B, et al. Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration. J Cardiac Fail 2008;14:515-520 (Pubitemid 352040860)